The $50,000 Cure Problem: Why the US Can't Do What India Already Did | Andy Holt & Phil Vanek
Listen on:
Listen on:
CategoryHealth & Fitness
About this episode
Andy Holt is the Chief Commercial Officer at Viralgen Vector Core, a company specializing in the contract manufacture of AAV gene therapies. A self-described "really bad molecular biologist" who moved to the commercial side, Andy has spent 18 years in cell and gene therapy, including a stint as VP at AskBio before its acquisition by Bayer.Phil Vanek is the Chief Commercialization Officer at ISCT (…
Andy Holt is the Chief Commercial Officer at Viralgen Vector Core, a compan…
Tags
#cancer#investing#podcast#wellness
Open Door Salon
About the show
Why Healthcare Works The Way It Does - Explained By the People Inside of It.